Home -> Law Blog Directory -> Legal Research Blogs -> Slaw.ca
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Legal Research
: Slaw.caThis Week?s Biotech Highlights
By Jeremy Grushcow
This week the biotech world was consumed with questions about genes, and patents, and patents on genes.
U.S. District Court Judge Robert Sweet issued a summary judgment ruling (pdf) that Myriad Genetics’ patents on the BRCA1 and BRCA2 genes were invalid, as were the patents on Myriad’s tests using those genes. Meh. The commentary (including here at Slaw) has been interesting and the public airing of patent policy is much needed and generally productive; but I don’t think the ruling is that big a deal.
In a case of superior serendipity, last week also marked the ten-year anniversary of the first draft of the human genome. The journal Nature marked the occassion with a special issue that contains looks back, looks forward, futurism, skepticism, at least one good mystery and lots of good data.
Stay tuned to The Cross-Border Biotech Blog and on Twitter @crossborderbio for news from this week’s BioFinance conference in Toronto and other industry developments.
Full post as published by Slaw.ca on April 06, 2010 (boomark / email).
Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.

London Biotech week - Sept 22-26
BIO CEO Outlines Challenges for Obama Administration
ACI "Biotech Patents" Conference, Boston, September 15-16
Biotech Patents: How To Face New Challenges
What Can Biotech Do For You Just Ask.
Biotech/Pharma Lobbying Scoreboard - Third Quarter Update - Part II









